A breast cancer vaccine has shown promise in a phase 1 trial spearheaded by researchers at University of Washington’s Cancer Vaccine Institute and is preparing to move to phase 2, a July 17 Fred Hutchinson Cancer Center news release said.
Read the full post on Becker's Hospital Review - Healthcare News
